Effects of levodopa on upper limb mobility and gait in Parkinson’s disease

Table 3

Correlations between the unified Parkinson’s disease rating scale motor score (UPDRS III), finger tapping test, and gait variables: r² values

		NH*	GV†	CAD‡	SL¶
*Number of hits in the best finger tapping test of the most affeated upper limb in the OFF state.
†Gait velocity (m/min) in the best walking trial.
‡Gait cadence (steps/min) in the best walking trial.
¶Stride length (m) in the best walking trial.
p < 0.05; *p < 0.01.
OFF, OFF state; ON, ON state; Δ, OFF-ON variation.
UPDRS III	OFF	0.5804**	0.2103*	0.0679	0.1996*
	ON	0.3708**	0.1173	0.0611	0.0848
	Δ	0.0383	0.0143	0.0033	0.0242
NH*	OFF		0.3860**	0.2731*	0.1916*
	ON		0.3811**	0.2387*	0.2506*
	Δ		0.0568	0.0185	0.0098
GV†	OFF			0.3836**	0.7351**
	ON			0.7574**	0.4326**
	Δ			0.0514	0.5641**
CAD‡	OFF				0.0220
	ON				0.0450
	Δ				0.2119*

This Article

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Effects of levodopa on upper limb mobility and gait in Parkinson’s disease

This Article

Latest from Practical Neurology

BMJ Careers - Latest Neurology and Neurosurgery jobs